Cytek Biosciences (CTKB) vs OrthoPediatrics (KIDS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cytek Biosciences (CTKB) has outperformed OrthoPediatrics (KIDS) over the past year, gaining 37.4% versus a gain of 20.2%. Over five years, KIDS leads with a -65.4% price change compared with -77.7% for CTKB. Cytek Biosciences is the larger company by market cap ($698.0 million vs $562.7 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTKB | KIDS |
|---|---|---|
| Share price | $5.37 | $21.55 |
| Market cap | $698.01M | $562.67M |
| 1-day change | +0.19% | -0.97% |
| YTD return | +6.14% | +22.52% |
| 1-year return | +37.44% | +20.22% |
| 5-year return | -77.73% | -65.42% |
| Forward P/E | 76.71 | — |
| EPS (TTM) | $-0.62 | $-1.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.21 | $26.74 |
| 52-week low | $3.31 | $14.42 |
| Distance from 52-week high | -13.53% | -19.41% |
| Analyst consensus | none | none |
| Avg. price target upside | +3.54% | +26.31% |
| Average volume | 1.05M | 209.38K |
| Shares outstanding | 129.98M | 26.11M |
| Employees | 682 | 602 |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CTKB has outperformed KIDS by 17.2 percentage points over the past year.
- The two companies sit in different sectors: Cytek Biosciences in Industrials and OrthoPediatrics in Health Care.
About Cytek Biosciences
CTKB stock →Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems.
Industrials · Biotechnology: Laboratory Analytical Instruments · 682 employees
About OrthoPediatrics
KIDS stock →OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Health Care · Medical/Dental Instruments · 602 employees
CTKB vs KIDS FAQ
Which is bigger, Cytek Biosciences or OrthoPediatrics?
Cytek Biosciences (CTKB) is larger, with a market capitalization of $698.01M compared with $562.67M for OrthoPediatrics (KIDS).
Which stock has performed better over the past year, CTKB or KIDS?
CTKB returned +37.44% over the past 12 months, compared with +20.22% for KIDS (price return, excluding dividends). Past performance does not predict future results.
Are Cytek Biosciences and OrthoPediatrics in the same industry?
No. Cytek Biosciences is in the Industrials sector, while OrthoPediatrics is in Health Care.